Nicholas Dominic Cortezi Sells 35,000 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) Stock

Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Nicholas Dominic Cortezi sold 35,000 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $66.35, for a total transaction of $2,322,250.00. Following the completion of the transaction, the director now owns 20,909 shares in the company, valued at $1,387,312.15. This represents a 62.60 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Nicholas Dominic Cortezi also recently made the following trade(s):

• On Friday, January 17th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $67.15, for a total transaction of $2,350,250.00.
• On Wednesday, January 15th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $65.99, for a total transaction of $2,309,650.00.
• On Monday, January 13th, Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock. The stock was sold at an average price of $65.06, for a total value of $1,917,057.96.
• On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The stock was sold at an average price of $65.00, for a total value of $5,915.00.
• On Wednesday, December 18th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $65.17, for a total value of $2,280,950.00.
• On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $66.71, for a total value of $2,334,850.00.
• On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $67.39, for a total transaction of $2,358,650.00.

Ryan Specialty Trading Down 1.6 %

NYSE RYAN opened at $65.66 on Thursday. The stock’s fifty day moving average price is $67.63 and its 200-day moving average price is $66.12. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock has a market cap of $17.19 billion, a P/E ratio of 85.27, a P/E/G ratio of 1.16 and a beta of 0.72. Ryan Specialty Holdings, Inc. has a 12 month low of $42.21 and a 12 month high of $75.97.

Ryan Specialty (NYSE:RYAN) last issued its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.41. The business had revenue of $604.69 million during the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The business’s revenue for the quarter was up 20.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.32 earnings per share. As a group, equities analysts forecast that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were given a $0.11 dividend. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 annualized dividend and a yield of 0.67%. Ryan Specialty’s dividend payout ratio (DPR) is presently 57.14%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on RYAN. Wells Fargo & Company reduced their price target on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 14th. Bank of America lifted their price objective on Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research report on Thursday, October 10th. Barclays increased their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, November 21st. The Goldman Sachs Group lifted their price target on Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research report on Wednesday, October 9th. Finally, Keefe, Bruyette & Woods decreased their price objective on Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating for the company in a report on Friday, January 10th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $74.40.

Institutional Trading of Ryan Specialty

A number of institutional investors and hedge funds have recently modified their holdings of RYAN. Mutual of America Capital Management LLC bought a new stake in shares of Ryan Specialty in the second quarter worth approximately $3,394,000. Amalgamated Bank boosted its holdings in Ryan Specialty by 441.7% in the second quarter. Amalgamated Bank now owns 53,435 shares of the company’s stock worth $3,094,000 after purchasing an additional 43,570 shares during the last quarter. Vanguard Personalized Indexing Management LLC bought a new stake in Ryan Specialty in the 2nd quarter worth approximately $248,000. Thrivent Financial for Lutherans raised its stake in Ryan Specialty by 519.6% during the 2nd quarter. Thrivent Financial for Lutherans now owns 28,803 shares of the company’s stock valued at $1,668,000 after buying an additional 24,154 shares during the last quarter. Finally, ProShare Advisors LLC bought a new position in shares of Ryan Specialty during the 2nd quarter valued at $280,000. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.